Artivion to Participate in Upcoming Investor Conferences
ATLANTA, Nov. 5, 2024 /PRNewswire/ — Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences. Artivion’s management team will present at the upcoming Stifel 2024
SenesTech to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Nov. 5, 2024 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2024, ended September 30, 2024, after the market close on Tuesday, Novemb
Jack Henry & Associates, Inc. Reports First Quarter Fiscal 2025 Results
First quarter summary: GAAP revenue increased 5.2% and GAAP operating income increased 14.0% for the fiscal three months ended September 30, 2024, compared to the prior fiscal year quarter. Non-GAAP adjusted revenue increased 5.3% and non-GAAP adjusted operating income increased 1.6% for the fisc
Star Holdings Reports Third Quarter 2024 Results
NEW YORK, Nov. 5, 2024 /PRNewswire/ — Star Holdings (NASDAQ: STHO) announced today that it has filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 with the Securities and Exchange Commission. Net income attributable to common shareholders for the third quarter wa
Grand Opening: The Greater Danbury, CT Area’s Largest Self-Storage Facility
PURCHASE, N.Y., Nov. 5, 2024 /PRNewswire/ — dSA Capital LLC and Extra Space Storage are excited to announce the grand opening of its newest self-storage facility in Brookfield, CT, located less than half a mile from the Danbury city limits. The state-of-the-art, four-story building spans 110,0
Marvell Technology, Inc. Announces Conference Call to Review Third Quarter of Fiscal Year 2025 Financial Results
SANTA CLARA, Calif., Nov. 5, 2024 /PRNewswire/ — Marvell Technology, Inc. (NASDAQ: MRVL), a leader in infrastructure semiconductor solutions, today announced it will conduct a conference call following the release of its third quarter of fiscal year 2025 financial results on Tuesday, December
New Study Compares Caldolor® (ibuprofen injection) to ketorolac
– Real World Study Compared Over 150,000 Adult & Pediatric Patients –– Caldolor Associated with Fewer Adverse Drug Reactions –– Caldolor also Improved Healthcare Utilization – NASHVILLE, Tenn., Nov. 5, 2024 /PRNewswire/ — Specialty phar
Poseida Therapeutics to Present Clinical and Preclinical Data on Investigational Allogeneic CAR-T Cell Therapies at SITC 2024 and ASH 2024
New preclinical data on allogeneic CAR+TCR-T cells rich in stem cell memory T cells (TSCM) and enhanced potency to better target solid tumors will be presented at SITC Additional profiling of patient responses in P-BCMA-ALLO1 Phase 1 Arm C and preclinical P-CD19CD20-ALLO1 to be presented at ASH SAN
Nordstrom to Report Third Quarter 2024 Financial Results on November 26
SEATTLE, Nov. 5, 2024 /PRNewswire/ — Nordstrom, Inc. (NYSE: JWN) announced that it will report its third quarter 2024 financial results after the close of the financial markets on Tuesday, November 26, 2024. The announcement will be followed by a conference call at 4:45 p.m. EST, in which seni
Qualys Announces Third Quarter 2024 Financial Results
Revenue Growth of 8% Year-Over-Year GAAP EPS: $1.24; Non-GAAP EPS: $1.56Raises 2024 Revenue Guidance to $602.9–$605.9 millionRaises 2024 GAAP EPS Guidance to $4.31–$4.41Raises 2024 Non-GAAP EPS Guidance to $5.81–$5.91 FOSTER CITY, Calif., Nov. 5, 2024 /PRNewswire/ — Qualys,
